ALAB vs CLOV
Astera Labs, Inc. Common Stock (ALAB) versus Clover Health Investments Corp (CLOV) — a side-by-side from cached financials, not a winner call.
Astera Labs, Inc. Common Stock (ALAB) is a semiconductors company listed on US.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Latest reported ALAB revenue for 2024-12-31 was $396.3M. Net income was -$83.4M. Revenue was up 242.2% from 2023-12-31 to 2024-12-31. ALAB currently screens at market cap $16.84B and trailing P/E 78.0.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
ALAB currently screens at market cap $16.84B and trailing P/E 78.0. CLOV currently screens at market cap $1.55B.
Not investment advice. Open the ALAB and CLOV stock pages for the full models.
Not investment advice.